On Sunday, July 19, 2026, the FDA announced that its laboratory re-check of a Taylor Farms lettuce sample previously reported as positive for Cyclospora should be considered a false positive. As of that same date, the agency stated there were no confirmed positive sample results for Cyclospora in connection with the outbreak investigation The Guardian.

The reversal came just one day after the FDA's initial report. On Saturday, July 18, the agency had said a sample of shredded iceberg lettuce supplied by Taylor Farms tested positive for Cyclospora, linking the supplier to a multi-state outbreak that had already sickened consumers across five states Reuters.

Taylor Fresh Foods, the parent company of Taylor Farms, responded quickly to the initial finding. The company completed a voluntary recall of iceberg lettuce sourced from central Mexico, acting, it said, out of an abundance of caution based on the FDA's preliminary information. A Taylor Fresh Foods spokesperson told Reuters that the company was subsequently informed the FDA had made a mistake. The company also stated that the FDA apologized to Taylor Farms directly The Guardian. Taylor Fresh Foods published an official statement on its corporate newsroom on July 19 addressing the outbreak and the agency's revised determination Taylor Farms Newsroom.

The Cyclospora outbreak itself remains a real public health event, distinct from the laboratory error. According to the CDC, the outbreak resulted in approximately 100 hospitalizations and no deaths. The parasite was linked to shredded iceberg lettuce served at Yum Brands Taco Bell restaurants across Indiana, Kentucky, Michigan, Ohio, and West Virginia The Guardian.

The FDA, in its latest update, stated that it had notified Taylor Farms and continues to work with the firm to ensure the product implicated in the outbreak has been removed from the market. That language signals the agency is not retreating from its broader investigation, even as it walks back the specific laboratory finding that named Taylor Farms as a positive sample The Guardian.

The agency's communications strategy has drawn some attention. The FDA's press announcements landing page, as of July 17, does not feature a dedicated press release about the false positive. Instead, it contains a "Recall Alert" linking to the outbreak investigation page housed under the Food section of the FDA website at fda.gov/food/outbreaks-foodborne-illness/ rather than under News & Events or Press Announcements FDA Press Announcements. Reuters confirmed the retraction in a July 20 article headlined "FDA says Taylor Farms cyclospora finding was a false positive" Reuters.

The broader context here involves the reliability of regulatory laboratory diagnostics during active foodborne illness investigations. The FDA's initial positive result for Cyclospora in the Taylor Farms sample triggered a recall, a supplier-level investigation, and public attribution to a specific company, all within roughly 48 hours. The subsequent retraction raises questions about the confirmation protocols governing preliminary pathogen detections that are disclosed to the public and to industry partners before secondary verification is complete. In this case, the recall was voluntary and precautionary, and no deaths were reported, which limits the immediate harm. But for a supplier of Taylor Farms' scale, the reputational and supply-chain consequences of an erroneous public finding can be substantial, even when corrected quickly.

The episode also underscores a structural tension in outbreak communication: the FDA's mandate to move swiftly when public health is at risk can conflict with the precision that confirmatory testing requires. The agency has not, based on available information, detailed what specifically caused the false positive, whether it was a contamination of the testing reagents, cross-contamination in the lab, or an analytical error. That gap leaves food safety professionals and industry compliance teams without a clear explanation of the failure mode, which matters for assessing whether similar errors could recur in future investigations.

For now, the outbreak investigation continues, Taco Bell's supply chain has been implicated through epidemiological linkage, and Taylor Farms has been cleared of the specific laboratory finding that initially drew regulatory scrutiny. The product removal the FDA references appears to remain in effect, suggesting the agency still considers the broader epidemiological evidence sufficient to warrant continued market intervention even without a confirmed positive lab sample from the named supplier.